GLP-1 vs Insulin Degludec

Head-to-head comparison of GLP-1 (Glucagon-like peptide-1 (7-36 amide)) and Insulin Degludec (Insulin degludec (desB30, acylated ultra-long-acting insulin analog)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyGLP-1Insulin Degludec
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameGlucagon-like peptide-1 (7-36 amide)Insulin degludec (desB30, acylated ultra-long-acting insulin analog)
Molecular Weight3297 Da6103.9 Da
Half-Life1-2 minutesMore than 25 hours
Amino Acids3050
Typical DoseResearch-only: 0.1-1.0 pmol/kg/min0.1-0.2 U/kg once daily
RouteIntravenous/SubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count12007000
Research StatusPre-clinicalApproved

GLP-1 Benefits

  • beta-cell protection
  • improved insulin secretion
  • slower gastric emptying
  • lower postprandial glucose

Insulin Degludec Benefits

  • Ultra-long basal coverage
  • Lower day-to-day variability
  • Reduced nocturnal hypoglycemia
  • Flexible dosing time

GLP-1 Dosing

0.1-1.0 pmol/kg/min IV infusion in research|0.5-10 nM in vitro|continuous delivery in animal studies

Insulin Degludec Dosing

Inject SC once daily|Titrate to fasting glucose and HbA1c response|May be administered with flexible timing in adults

GLP-1 Side Effects

  • nausea at pharmacologic exposure
  • tachyphylaxis with continuous exposure
  • headache

Insulin Degludec Side Effects

  • Hypoglycemia
  • Injection-site reactions
  • Weight gain

Research Overview

GLP-1

Native GLP-1 has a very short half-life because of rapid DPP-4 cleavage, so it is mainly used as a mechanistic research peptide. Across animal and cellular studies it reduces beta-cell apoptosis, improves insulin gene expression, and enhances islet resilience.

Insulin Degludec

Studies highlight prolonged action and lower glycemic variability compared with many other basal insulins. It is frequently used in research on ultra-long basal coverage and hypoglycemia reduction.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

GLP-1 stacks with:

DPP-4 inhibitorsSGLT2 inhibitorsdiet and exercise

Insulin Degludec stacks with:

Insulin LisproInsulin Aspart
incretinbeta-cell survivalDPP-4 substrateultra-long-acting insulinbasal controllow variability